Nerve block may curb ICU delirium in seniors
NCT ID NCT07558642
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests whether a stellate ganglion block (a nerve injection) can reduce delirium (sudden confusion) and improve sleep-wake cycles in intensive care patients aged 65 and older. Delirium is common in the ICU and linked to worse outcomes. The trial will compare 130 patients who receive the block with those who do not, measuring confusion levels and blood markers of circadian rhythm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STELLATE GANGLION BLOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antalya Training and Research Hospital
Antalya, Muratpaşa, 07100, Turkey (Türkiye)
-
Antalya Training and Research Hospital
Antalya, Muratpaşa, 07100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound reveals how a neck nerve block may impact the diaphragm
- Nerve block may boost brain recovery after hemorrhagic stroke
- Magnesium may boost pain relief after mastectomy
- Nerve block calms deadly heart storms in small trial
- Simple nerve block could prevent Post-Surgery heart rhythm problems
- Nerve block before surgery may boost sleep and recovery in brain injury patients